middle.news
Memphasys Advances Global Reach with Felix™ System Trials and Strategic Partnerships
2:01pm on Thursday 23rd of January, 2025 AEDT
•
Biotechnology
Read Story
Memphasys Advances Global Reach with Felix™ System Trials and Strategic Partnerships
2:01pm on Thursday 23rd of January, 2025 AEDT
Key Points
Felix™ System clinical trials completed at Monash IVF, enabling CE Mark submission
Strategic partnerships secured in Greater China and UAE for market entry
RoXsta™ System gains provisional patent approval and begins cattle fertility study
Raised $1.905 million to accelerate commercialisation efforts
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE